4Stratton Lm,AdlerA1,NeilHA,eta.l Assosiation ofglycaemiawithma crovascular and microvas culorcom placations of type 2 diabetes prospectiveobservationalStudy.BMJ,2000,321:405-405.
二级参考文献9
1Wahren J,Shafqat J,Johansson J,et al.Molecular and Cellular Effects of C-peptide《《New Perspectives on an Old Peptide.Experimental Di-ab,2004,5:15-23.
2Kont T,Schneider S,Pfutaner A,et al.The effect of human proinsulin C-peptide on erythrocyte deformability in patients with type 1 diabetes mellitus Diabetologia,1999,42:465-471.
3Bague P,Coste TC,Jannot MF,et al.C-peptide,Na^+-K^+-ATPase and Diabetes,Experimental Diab,2004,5:37-50.
4Ido Y,Vindigni A,Chang K,et al.Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.Science,1997,277:563-566.
5Ekberg K,Brismar T,Johansson BL,et al.Amelioration of sensory nerve dysfunction by C-paptide in patients with type 1 diabetes.Diabe-tes,2003,52:536-541.
6Cotter MA,Ekberg K,Wahren J,et al.Effects of proinsulin C-peptide in experimental diabetic neuropathy:vascular actions and modulation by nitric oxide synthase inhibition.Diabetes,2003,52:1812-1817.
7Danida M,Emilia R,Angela Marie A,et al.Residual C-peptide se-cretion and endothelial function in patients with Type 2 diabetes.Clini-cal Scienee,2003,105:113-118.
